These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8222873)

  • 21. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal prophylaxis in neutropenic patients with hematologic malignancies.
    Böhme A; Karthaus M; Hoelzer D
    Antibiot Chemother (1971); 2000; 50():69-78. PubMed ID: 10874456
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
    Minenko SV; Zhukov NV; Chimishkian KL; Sokolova EN; Ptushkin VV
    Antibiot Khimioter; 2004; 49(8-9):52-6. PubMed ID: 15727147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluconazole versus oral amphotericin B in preventing fungal infection in chemotherapy-induced neutropenic patients with haematological malignancies.
    Akiyama H; Mori S; Tanikawa S; Sakamaki H; Onozawa Y
    Mycoses; 1993; 36(11-12):373-8. PubMed ID: 7935568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fungal pathogens and primary antifungal prophylaxis in patients with hematological malignancies: one year experience.
    Gedik H; Yildirmak MT; Simsek F; Aydin D; Demirel N; Yokus O; Arica D
    Afr Health Sci; 2012 Sep; 12(3):390-4. PubMed ID: 23382758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study.
    Shen Y; Huang XJ; Wang JX; Jin J; Hu JD; Yu K; Wu DP; Wang SJ; Yu L; Chen XQ; Liu T; Liang YM; Chen FP; Li Y; Shen ZX
    Int J Clin Pharmacol Ther; 2013 Sep; 51(9):738-45. PubMed ID: 23924680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of oral fluconazole and amphotericin B prophylaxis against fungal infections in the neutropenic phase of patients treated with antileukemic agents].
    Finke R
    Mycoses; 1990; 33 Suppl 1():42-54. PubMed ID: 2101864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.
    van Burik JA; Ratanatharathorn V; Stepan DE; Miller CB; Lipton JH; Vesole DH; Bunin N; Wall DA; Hiemenz JW; Satoi Y; Lee JM; Walsh TJ;
    Clin Infect Dis; 2004 Nov; 39(10):1407-16. PubMed ID: 15546073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical course and risk of fungal infections development in children with treated with chemo- and radiotherapy for solid tumors].
    Balcerska A; Drozyńska E; Stefanowicz J; Bień E; Szutowicz E; Czarniak P
    Pol Tyg Lek; 1995 Sep; 50(36-39):70-2. PubMed ID: 8650039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candida glabrata, Candida krusei, non-albicans Candida spp., and other fungal organisms in a sixty-bed national cancer center in 1989-1993: no association with the use of fluconazole.
    Kunová A; Trupl J; Spánik S; Drgona L; Sufliarsky J; Lacka J; Studená V; Hlavácová E; Studená M; Kukucková E
    Chemotherapy; 1995; 41(1):39-44. PubMed ID: 7875020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antifungal therapy for infants, children and adolescents with suspected or documented invasive fungal infection].
    Odio CM
    Drugs Today (Barc); 2010 Apr; 46 Suppl C():33-46. PubMed ID: 20490381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group.
    Ninane J
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):330-7. PubMed ID: 7794307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S
    Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive fungal infections in pediatric patients with hematologic malignancies receiving oral amphotericin B solution and early intravenous administration of fluconazole.
    Watanabe N; Matsumoto K; Kojima S; Kato K
    J Pediatr Hematol Oncol; 2011 May; 33(4):270-5. PubMed ID: 21464763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifungal prophylaxis during neutropenia or allogeneic bone marrow transplantation: what is the state of the art? Ad HOC Working Group.
    Denning DW; Donnelly JP; Hellreigel KP; Ito J; Martino P; van't Wout JW
    Chemotherapy; 1992; 38 Suppl 1():43-9. PubMed ID: 1611930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical study of fluconazole for the treatment of deep mycoses.
    Ikemoto H
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):239S-247S. PubMed ID: 2556241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance of triazole susceptibility of colonizing yeasts in patients with haematological malignancies.
    Chryssanthou E; Cherif H; Petrini B; Kalin M; Björkholm M
    Scand J Infect Dis; 2004; 36(11-12):855-9. PubMed ID: 15764173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.